Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prostatic Artery Embolization for Obstructive Uropathy Due to Prostate Cancer

NCT03104907 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT03104907
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03104907 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prostatic Artery Embolization for Obstructive Uropathy Due to Prostate Cancer
Lead sponsor
Rigshospitalet, Denmark
Phase
Not applicable
Overall status
Completed
Start date
March 22, 2017
Completion date
November 27, 2018
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lower urinary tract symptoms, prostatic diseases, prostatic neoplasm, urological manifestations